Baclofen And Acamprosate Based Therapy Of Neurological Disorders


The full document isn't yet available to us from the patent office.


The present invention relates to combinations and methods for the treatment of neurological disorders related to glutamate excitotoxicity and Amyloid ² toxicity. More specifically, the present invention relates to novel combinatorial therapies of Multiple Sclerosis, Alzheimer's disease, Alzheimer's disease related disorder, Amyotrophic Lateral Sclerosis, Parkinson's disease, Huntington's disease, neuropathic pain, alcoholic neuropathy, alcoholism or alcohol withdrawal, or spinal cord injury, based on Baclofen and Acamprosate combination.


Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Oct 29, 2014
  • Application: Mar 1, 2012
    EP EP 13196468 A
  • Priority: Mar 1, 2012
    EP EP 12708113 A
  • Priority: Mar 1, 2012
    EP EP 13196468 A
  • Priority: Jun 6, 2011
    EP EP 11305687 A
  • Priority: Jun 6, 2011
    US US 201161493606 P
  • Priority: Mar 29, 2011
    US US 201161468658 P
  • Priority: Mar 1, 2011
    EP EP 11305217 A

Download Citation

Sign in to the Lens